Breaking News Instant updates and real-time market news.

YGYI

Youngevity

$7.32

0.01 (0.14%)

08:33
02/13/19
02/13
08:33
02/13/19
08:33

Youngevity acquiring all assets of Khrysos Global for $16M

Youngevity has entered into a binding agreement to purchase all the assets of Khrysos Global - a Tampa, Florida based manufacturer of hemp-based CBD extraction equipment. This acquisition is intended to establish YGYI's newly formed wholly-owned subsidiary, Khrysos Industries, in the field-to-finish hemp-CBD oil, isolate, and distillate market, and also would give YGYI ownership of INX Labs and its testing facilities, allowing the company unprecedented capabilities in regards to formulation, quality control, and testing standards with its CBD products. All assets of Khrysos Global are to be acquired by YGYI, including all real property, joint venture agreements, contracts rights, intellectual property, trademarks, copyrights, and service marks in exchange for a total consideration of $16M, of which 1,794,972 shares of common stock and $500K will be paid at closing. In addition, YGYI agreed to issue to the principals of Khrysos contingent consideration warrants to purchase up to 3M shares of Common Stock at an exercise price of $10 per share upon the achievement of certain revenue and net income milestones. The closing of the transactions is scheduled for February 15.

YGYI Youngevity
$7.32

0.01 (0.14%)

08/10/18
BNCH
08/10/18
INITIATION
Target $7
BNCH
Buy
Youngevity initiated with a Buy at Benchmark
Benchmark started Youngevity with a Buy rating and $7 price target.
08/10/18
08/10/18
INITIATION
Target $7

Buy
Benchmark starts Youngevity with Buy rating, $7 price target
As previously reported, Benchmark analyst Bill Sutherland started Youngevity with a Buy rating and $7 price target, stating that he believes the stock has yet to reflect a return to organic revenue growth and rising margins for the Direct Selling segment as well as a just-announced, 5-year green coffee bean supply contract that he believes should push the Coffee segment to "meaningful profitability" in 2019.
02/13/19
BNCH
02/13/19
NO CHANGE
Target $14
BNCH
Buy
Youngevity price target raised to $14 from $9 at Benchmark
Benchmark analyst Bill Sutherland noted that Youngevity announced the purchase of the assets of Khrysos Global, a Florida-based manufacturer of hemp-based CBD extraction equipment, which he said can be used to create a multi-faceted CBD vertical. After increasing his 2019 model to "conservatively" reflect Khrysos, which he believes will grow quickly, Sutherland raised his price target on Youngevity shares to $14 from $9 and keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

CLSH

CLS Holdings

08:08
02/22/19
02/22
08:08
02/22/19
08:08
Initiation
CLS Holdings initiated  »

CLS Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNI

ATN International

$59.50

-15.62 (-20.79%)

08:08
02/22/19
02/22
08:08
02/22/19
08:08
Upgrade
ATN International rating change  »

ATN International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 22

    Mar

  • 28

    Mar

MDRX

Allscripts

$11.93

-0.21 (-1.73%)

08:07
02/22/19
02/22
08:07
02/22/19
08:07
Downgrade
Allscripts rating change  »

Allscripts downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTV

Veritiv

$35.55

-0.26 (-0.73%)

08:07
02/22/19
02/22
08:07
02/22/19
08:07
Hot Stocks
Veritiv to optimize wide format products business »

Veritiv announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Mar

APPN

Appian

$38.73

0.41 (1.07%)

08:06
02/22/19
02/22
08:06
02/22/19
08:06
Recommendations
Appian analyst commentary  »

Appian getting closer to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 07

    Mar

K

Kellogg

$58.33

-0.13 (-0.22%)

08:06
02/22/19
02/22
08:06
02/22/19
08:06
Hot Stocks
Kellogg elects Erica Mann, Roderick Gillum to board »

Kellogg announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 03

    Mar

SYNL

Synalloy

$12.94

0.11 (0.86%)

08:05
02/22/19
02/22
08:05
02/22/19
08:05
Hot Stocks
Synalloy announces stock repurchase program for up to 850,000 shares »

Synalloy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIDU

Baidu

$171.72

0.64 (0.37%)

08:05
02/22/19
02/22
08:05
02/22/19
08:05
Recommendations
Baidu analyst commentary  »

Baidu price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

MYL

Mylan

$31.06

-0.54 (-1.71%)

08:04
02/22/19
02/22
08:04
02/22/19
08:04
Hot Stocks
Mylan announces U.S. launch of generic Suboxone Sublingual Film »

Mylan announced the U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

OBLN

Obalon Therapeutics

$2.17

0.07 (3.33%)

08:03
02/22/19
02/22
08:03
02/22/19
08:03
Earnings
Obalon Therapeutics reports Q4 EPS (39c), consensus (36c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 18

    May

TTD

Trade Desk

$150.18

0.07 (0.05%)

08:03
02/22/19
02/22
08:03
02/22/19
08:03
Recommendations
Trade Desk analyst commentary  »

Trade Desk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 06

    Mar

HTH

Hilltop Holdings

$19.63

0.06 (0.31%)

08:03
02/22/19
02/22
08:03
02/22/19
08:03
Hot Stocks
Hilltop Holdings announces retirement of co-CEO Alan White »

Hilltop Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$78.76

-1.26 (-1.57%)

, VYGR

Voyager Therapeutics

$10.70

-0.19 (-1.74%)

08:02
02/22/19
02/22
08:02
02/22/19
08:02
Hot Stocks
AbbVie, Voyager Therapeutics partner to develop vectorized antibodies »

AbbVie (ABBV) and Voyager…

ABBV

AbbVie

$78.76

-1.26 (-1.57%)

VYGR

Voyager Therapeutics

$10.70

-0.19 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 11

    Mar

  • 18

    May

VNTR

Venator Materials

$6.40

0.115 (1.83%)

08:01
02/22/19
02/22
08:01
02/22/19
08:01
Initiation
Venator Materials initiated  »

Venator Materials resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

08:01
02/22/19
02/22
08:01
02/22/19
08:01
Recommendations
Kraft Heinz analyst commentary  »

Kraft Heinz price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCS

Marcus

08:01
02/22/19
02/22
08:01
02/22/19
08:01
Recommendations
Marcus analyst commentary  »

Marcus price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Apr

  • 02

    Apr

  • 06

    Jun

NE

Noble Corp.

$3.12

-0.2 (-6.02%)

08:00
02/22/19
02/22
08:00
02/22/19
08:00
Downgrade
Noble Corp. rating change  »

Noble Corp. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

SO

Southern Company

$50.22

0.48 (0.97%)

07:59
02/22/19
02/22
07:59
02/22/19
07:59
Upgrade
Southern Company rating change  »

Southern Company upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDRX

Allscripts

$11.93

-0.21 (-1.73%)

07:59
02/22/19
02/22
07:59
02/22/19
07:59
Downgrade
Allscripts rating change  »

Allscripts downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ES

Eversource

$70.50

0.23 (0.33%)

07:58
02/22/19
02/22
07:58
02/22/19
07:58
Downgrade
Eversource rating change  »

Eversource downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

KEYS

Keysight Technologies

$81.74

0.67 (0.83%)

07:56
02/22/19
02/22
07:56
02/22/19
07:56
Recommendations
Keysight Technologies analyst commentary  »

Keysight Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

CBOE

Cboe Global Markets

$94.92

-0.19 (-0.20%)

07:55
02/22/19
02/22
07:55
02/22/19
07:55
Initiation
Cboe Global Markets initiated  »

Cboe Global Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 28

    May

LRCX

Lam Research

$178.83

-3.28 (-1.80%)

07:54
02/22/19
02/22
07:54
02/22/19
07:54
Downgrade
Lam Research rating change  »

Lam Research downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

TDS

Telephone and Data

$36.69

-0.07 (-0.19%)

07:54
02/22/19
02/22
07:54
02/22/19
07:54
Earnings
Telephone and Data sees FY19 revenue $5.225B-$5.475B, consensus $5.14B »

Sees FY19: adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

OLED

Universal Display

$118.31

-0.57 (-0.48%)

07:53
02/22/19
02/22
07:53
02/22/19
07:53
Recommendations
Universal Display analyst commentary  »

Universal Display price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.